Scientific Advisor/Founder of Sphaera Pharma and Ferguson Distinguished Professor and Associate Dean, Research and Graduate Education, School of Pharmacy, The University of North Carolina at Chapel Hill.   Over 30 years of Drug Discovery and Development experience with tenures at National Institute of Arthritis, Metabolism and Digestive Diseases, NIH, and Glaxo Research Institute. Past, co-Editor-in-Chief of Medicinal Research Review; editorial board of Drug Metabolism and Disposition and member of the Basic Pharmacology Advisory Committee, Pharmaceutical Manufacturer's Association Foundation. Editorial board of Pharm. Sci.; advisory board of Office of Technology Development, UNC-Chapel Hill, Board of Directors, Qualyst Inc., Chesson Labs, and Advantium BioSciences . Special Emphasis Panel, National Institute of General Medical Sciences, NIH. Recipient of the Phillip Newmark Award for 'Excellence in Biochemical Research' at the University of Kansas; Sato Memorial International Award. PhD from the University of Kansas at Lawrence and has authored more than 140 publications.

 Basic Pharmacology, Drug Discovery and Development